studi
highlight
essenti
natur
group
small
highli
hydrophob
membran
embed
channelform
protein
life
cycl
grow
number
rna
virus
viroporin
mediat
flow
ion
rang
solut
across
cellular
membran
necessari
manipul
myriad
host
process
contribut
stage
viru
life
cycl
recent
discoveri
identifi
protein
encod
small
dna
tumor
virus
display
number
viroporin
like
properti
review
articl
summar
recent
develop
understand
novel
viroporin
describ
role
viru
life
cycl
pathogenesi
specul
potenti
target
antivir
therapeut
intervent
oblig
intracellular
parasit
virus
evolv
myriad
strategi
manipul
host
cell
environ
one
conduc
viru
replic
research
recent
decad
identifi
group
virusencod
protein
abl
mediat
passag
ion
solut
across
cellular
membran
term
viroporin
major
viroporin
describ
small
less
amino
acid
contain
one
two
transmembran
domain
tmd
although
small
number
larger
viroporin
shown
encod
three
put
tmd
whilst
highresolut
structur
inform
current
avail
limit
number
viroporin
bioinformat
approach
often
success
employ
identifi
key
featur
viroporin
lack
structur
inform
small
size
necessit
viroporin
must
oligomer
membran
form
activ
channel
complex
format
highord
complex
often
observ
mild
deterg
dhpc
like
mediat
hydrophob
interact
tmd
monom
although
viroporin
basic
residu
adjac
tmd
may
facilit
membran
bind
insert
known
viroporin
place
distinct
class
base
number
tmd
orient
carboxyl
termini
rel
endoplasm
reticulum
er
membran
undoubtedli
classif
system
use
catalogu
expand
number
viroporin
howev
need
adapt
order
accommod
viroporin
encod
three
tmd
also
need
take
account
dynam
natur
membran
protein
lipid
capabl
alter
orient
termini
depend
lipid
environ
modul
ionic
homeostasi
within
specif
cellular
compart
allow
viroporin
manipul
wide
rang
cellular
process
autophagi
traffick
inflamm
transform
cell
surviv
due
broad
perturb
host
cell
physiolog
surpris
viroporin
function
shown
assist
stage
viru
life
cycl
includ
entri
membran
penetr
genom
replic
viru
egress
exist
viru
encod
poreform
protein
initi
postul
nearli
four
decad
ago
howev
observ
protein
influenza
viru
iav
abl
form
tetram
rais
intracellular
ph
provid
first
clue
role
ion
channel
pioneer
studi
xenopu
oocyt
demonstr
current
could
block
addit
antivir
compound
amantadin
follow
viroporin
swiftli
identifi
number
rna
viru
famili
whilst
iav
remain
paradigm
viroporin
describ
number
viru
famili
includ
flavivirida
picornavirida
retrovirida
coronavirida
reovirida
paramyxovirida
date
overwhelm
major
viroporin
identifi
rna
virus
howev
given
myriad
cellular
process
abl
modul
logic
assum
virus
might
benefit
encod
protein
recent
find
identifi
protein
exhibit
number
viroporin
characterist
encod
member
polyomavirida
papillomavirida
review
summar
understand
put
viroporin
describ
known
function
attempt
highlight
possibl
ion
channel
activ
may
aid
life
cycl
small
dna
tumor
virus
polyomavirida
small
nonenvelop
doublestrand
dna
virus
infect
wide
rang
speci
famili
name
found
member
polyomaviru
caus
mani
tumor
mice
follow
prototyp
primat
polyomaviru
simian
vacuol
agent
rhesu
monkey
first
two
human
polyomavirus
discov
jc
bk
name
index
case
caus
seriou
diseas
immunocompromis
last
decad
seen
discoveri
sever
novel
human
polyomavirus
includ
merkel
cell
polyomaviru
caus
aggress
skin
cancer
discoveri
led
resurg
interest
polyomaviru
biolog
role
viru
encod
protein
pathogenesi
regard
two
member
famili
recent
shown
encod
protein
viroporin
characterist
progress
multifoc
leukoencephalopathi
pml
potenti
fatal
demyelin
diseas
brain
discov
later
attribut
novel
polyomaviru
term
jc
jc
widespread
amongst
adult
popul
studi
suggest
infect
rate
upward
possibl
high
despit
high
preval
pml
incid
extrem
low
due
tendenc
jc
result
asymptomat
latent
infect
kidney
lymphat
system
bone
marrow
immunocompet
individu
activ
viru
occur
almost
exclus
immunocompromis
patient
characteris
lytic
infect
oligodendrocyt
result
demyelin
develop
pml
although
clear
viru
infect
central
nervou
system
introduct
antivir
therapi
combat
progress
aid
pml
promin
featur
hiv
phenotyp
sinc
resurg
pml
case
wide
rang
immunosuppress
therapi
appli
combat
autoimmun
diseas
multipl
sclerosi
ms
aid
accept
transplant
tissu
link
jc
rang
human
cancer
also
report
although
disput
similar
polyomavirus
jc
encod
earli
protein
constitut
small
larg
antigen
mani
splice
variant
engag
mani
host
process
ensur
cellular
milieu
avail
conduc
viru
replic
addit
three
late
structur
protein
express
includ
major
capsid
protein
minor
capsid
protein
jc
encod
addit
late
protein
term
agnoprotein
agnoprotein
express
limit
number
polyomavirus
includ
relat
bk
amino
acid
agnoprotein
highli
basic
contain
central
hydrophob
region
capabl
form
amphipath
helix
concert
residu
amino
termin
region
amphipath
helix
requir
local
er
membran
insert
biochem
analysi
show
residu
within
amphipath
helix
necessari
suffici
dimer
oligom
format
agnoprotein
oligom
stabl
sd
depend
disulphid
bridg
format
recent
nuclear
magnet
reson
nmr
data
confirm
format
amphipath
helix
basic
natur
protein
may
provid
flexibl
within
amino
carboxyl
termini
increas
rang
interact
host
partner
list
known
jc
agnoprotein
bind
partner
see
tabl
viroporin
activ
associ
increas
plasma
membran
permeabl
result
elev
cytosol
calcium
level
similar
sever
known
viroporin
agnoprotein
express
manipul
host
traffick
pathway
allow
transport
agnoprotein
cell
surfac
mediat
plasma
membran
permeabil
achiev
agnoprotein
interact
subunit
adaptor
protein
complex
inhibit
function
consequ
prevent
traffick
agnoprotein
lysosom
destruct
substitut
two
basic
amino
acid
amino
termin
region
agnoprotein
prevent
interact
perturb
subcellular
local
abrog
plasma
membran
permeabil
seen
wild
type
protein
moreov
jc
virus
contain
either
agnoprotein
delet
alanin
substitut
basic
residu
result
compar
defect
virion
releas
infect
cell
conclus
studi
basic
residu
critic
requir
agnoprotein
function
potenti
contribut
toward
viroporin
activ
mutat
similar
basic
motif
hcv
protein
also
impair
viroporin
activ
assess
use
carboxylfluorescein
dye
releas
assay
howev
investig
fact
reveal
mutant
protein
longer
abl
integr
correctli
membran
plausibl
mutat
basic
loop
agnoprotein
membran
integr
perturb
would
expect
broader
impact
agnoprotein
function
beyond
inhibit
viroporin
function
agnoprotein
multipl
role
within
jc
life
cycl
known
requir
residu
within
amphipath
helix
may
depend
upon
viroporin
function
bind
larg
antigen
viral
origin
replic
enhanc
presenc
agnoprotein
agnoprotein
contain
mutat
would
expect
impair
amphipath
helix
format
display
decreas
larg
bind
significantli
reduc
viru
genom
replic
mutat
within
amphipath
helix
impact
protein
stabil
result
reduc
agnoprotein
express
impact
viru
replic
might
aris
result
less
agnoprotein
rather
loss
put
viroporin
activ
nevertheless
reduc
jc
replic
featur
observ
agnoprotein
delet
virus
indic
modul
replic
bona
fide
function
agnoprotein
polyomaviru
virion
assembl
nucleu
first
requir
exit
organel
cytoplasm
prior
egress
infect
cell
sinc
complet
lysi
nuclear
membran
would
abolish
integr
infect
cell
impair
viru
replic
jc
evolv
instead
alter
nuclear
envelop
ne
mediat
viru
egress
jc
infect
cell
show
protrus
invagin
ne
mediat
bind
agnoprotein
heterochromatin
normal
interact
laminb
receptor
lbr
assist
reassembl
ne
cell
divis
howev
amino
termin
domain
agnoprotein
capabl
bind
induc
disassoci
lbr
result
morpholog
chang
ne
allow
escap
progeni
virion
whether
viroporin
activ
requir
function
clear
although
bind
requir
amino
termin
residu
outsid
put
tmd
agnoprotein
shown
subject
extens
posttransl
modif
like
key
regul
function
protein
kinas
c
pkc
phosphoryl
jc
agnoprotein
three
identifi
residu
jc
virus
contain
alanin
substitut
site
less
abl
maintain
activ
infect
although
display
enhanc
agnoprotein
express
level
earli
time
point
infect
subsequ
studi
identifi
antagonist
role
protein
phosphatas
agnoprotein
phosphoryl
agnoprotein
dephosphoryl
shown
inhibit
jc
replic
level
compar
alanin
substitut
mutant
mechanist
jc
small
antigen
shown
bind
agnoprotein
thought
reduc
abil
dephosphoryl
agnoprotein
interestingli
deplet
jc
infect
cell
use
sirna
also
result
reduc
viru
replic
rais
intrigu
possibl
phosphoryl
dephosphoryl
form
agnoprotein
defin
function
interplay
two
contribut
success
replic
propag
jc
function
howev
yet
delin
phosphoryl
shown
import
regul
subcellular
local
protein
plausibl
phosphoryl
state
agnoprotein
may
determin
subcellular
locat
henc
role
play
replic
whether
also
requir
regul
viroporin
function
shown
howev
given
find
sawa
colleagu
viroporin
function
need
cell
surfac
possibl
phosphoryl
agnoprotein
may
also
contribut
local
channel
requir
regul
viroporin
posttransl
modif
would
add
anoth
tier
control
import
protein
jc
agnoprotein
share
signific
ident
agnoprotein
encod
relat
virus
bk
across
whole
protein
rise
amino
termin
region
figur
expect
high
homolog
agnoprotein
bk
appear
perform
similar
function
viru
life
cycl
although
subtl
differ
though
less
well
studi
loss
agnoprotein
appear
correl
defect
late
stage
viru
life
cycl
perturb
egress
addit
agnoprotein
may
also
play
role
packag
genom
bk
egress
recent
shown
sensit
did
compound
given
did
broadspectrum
inhibitor
ion
channel
possibl
target
action
agnoprotein
viroporin
would
interest
assess
impact
did
viru
egress
agnoprotein
knockout
viru
widerang
role
agnoprotein
identifi
jc
bk
coupl
deleteri
effect
seen
agnoprotein
defici
virus
warrant
seriou
analysi
potenti
agnoprotein
target
direct
act
antivir
therapeut
group
previous
gener
sirna
target
jc
agnoprotein
success
inhibit
viral
replic
mice
infect
brain
justifi
premis
target
protein
inhibit
studi
would
expedit
direct
analysi
channel
activ
use
recombin
agnoprotein
similar
pioneer
work
hcv
protein
would
affirm
channel
function
would
also
provid
platform
screen
larg
librari
compound
display
viroporin
inhibitori
properti
avail
three
late
protein
shown
aid
entri
releas
virtu
viroporinlik
properti
gener
success
met
residu
within
messeng
rna
share
common
carboxylterminu
class
minor
constitu
viru
particl
present
stoichiometri
one
copi
protein
per
pentam
given
nonenvelop
viru
evolv
strategi
allow
transport
incom
virion
membran
environ
cytoplasm
nucleu
initi
genom
replic
number
studi
shown
form
pore
cellular
membran
may
aid
deliveri
virion
nucleu
mutat
residu
within
put
tmd
prevent
membran
target
engin
genom
result
reduc
infect
also
encod
uniqu
late
protein
term
encod
transcript
unlik
late
protein
thought
incorpor
capsid
widerang
role
agnoprotein
identifi
jc
bk
coupl
deleteri
effect
seen
agnoprotein
defici
virus
warrant
seriou
analysi
potenti
agnoprotein
target
direct
act
antivir
therapeut
group
previous
gener
sirna
target
jc
agnoprotein
success
inhibit
viral
replic
mice
infect
brain
justifi
premis
target
protein
inhibit
studi
would
expedit
direct
analysi
channel
activ
use
recombin
agnoprotein
similar
pioneer
work
hcv
protein
would
affirm
channel
function
would
also
provid
platform
screen
larg
librari
compound
display
viroporin
inhibitori
properti
avail
three
late
protein
shown
aid
entri
releas
virtu
viroporinlik
properti
gener
success
met
residu
within
messeng
rna
share
common
carboxylterminu
class
minor
constitu
viru
particl
present
stoichiometri
one
copi
protein
per
pentam
given
nonenvelop
viru
evolv
strategi
allow
transport
incom
virion
membran
environ
cytoplasm
nucleu
initi
genom
replic
number
studi
shown
form
pore
cellular
membran
may
aid
deliveri
virion
nucleu
mutat
residu
within
put
tmd
prevent
membran
target
engin
genom
result
reduc
infect
also
encod
uniqu
late
protein
term
encod
transcript
unlik
late
protein
thought
incorpor
capsid
encod
singl
tmd
associ
membran
gener
channel
defin
pore
size
increas
membran
permeabl
express
least
h
later
late
protein
indic
potenti
role
viru
releas
channel
activ
regul
lipid
environ
show
greater
activ
liposom
mimick
composit
plasma
membran
virus
lack
exhibit
signific
defect
viru
spread
togeth
data
indic
viroporin
function
specif
latter
stage
life
cycl
whether
mammalian
polyomavirus
encod
protein
clear
current
uncertain
might
requir
polyomavirus
jc
agnoprotein
shown
permeabil
plasma
membran
may
therefor
fulfil
role
howev
given
sequenc
similar
like
agnoprotein
may
also
serv
viroporin
possibl
either
redund
cooper
agnoprotein
question
remain
unansw
viroporin
function
confirm
agnoprotein
papillomavirida
contain
extens
array
differ
papillomaviru
pv
type
capabl
infect
varieti
anim
speci
least
current
isol
human
like
polyomaviru
small
nonenvelop
doubl
strand
dna
virus
around
nm
diamet
pv
encod
six
earli
two
late
structur
gene
approxim
hpv
type
term
highrisk
caus
agent
sever
anogenit
oral
malign
import
respons
approxim
cervic
cancer
case
death
approxim
women
alon
low
risk
hpv
usual
clear
bodi
vaccin
avail
prophylact
treatment
high
risk
hpv
yet
therapeut
exist
case
hpv
infect
three
gene
product
mediat
transform
potenti
highrisk
hpv
major
driver
keratinocyt
prolifer
necessari
maintain
cell
cycl
differenti
keratinocyt
achiev
bind
inactiv
retinoblastoma
prb
tumor
suppressor
protein
repress
variou
cell
line
shown
induc
cellular
senesc
halt
differenti
protein
least
understood
three
oncoprotein
highli
hydrophob
amino
acid
membran
protein
resid
lumen
cytoplasm
membran
interact
grow
number
cellular
partner
figur
tripl
membran
span
topolog
determin
partial
membran
permeabil
fluoresc
studi
cell
support
idea
amino
terminu
resid
lumen
er
carboxyl
terminu
expos
cytosol
lack
specif
antibodi
preclud
local
studi
viru
infect
cell
howev
epitop
tag
shown
overexpress
studi
predominantli
local
er
golgi
membran
cell
surfac
local
also
note
although
disput
other
sequenc
analysi
demonstr
recogniz
gene
miss
sever
hpv
type
beta
gamma
mu
virus
encod
open
read
frame
show
signific
sequenc
diverg
result
protein
product
rang
size
approxim
amino
acid
signific
diverg
might
indic
distinct
role
within
hpv
life
cycl
depend
specif
viru
type
importantli
highrisk
cancer
caus
hpv
type
encod
protein
similar
approxim
acid
term
alpha
oligomer
vitro
cell
oligom
format
driven
presenc
disulphid
linkag
cystein
residu
rather
hydrophob
interact
individu
monom
laboratori
demonstr
oligom
could
mediat
control
releas
small
molecul
carboxyflourescein
use
liposom
dye
releas
assay
whilst
question
rais
valid
indirect
measur
channel
activ
wide
use
multipl
channel
eg
hcv
classic
swine
fever
viru
csfv
respiratori
syncyti
viru
rsv
sh
provid
import
insight
activ
stoichiometri
predict
hexamer
use
silico
model
subsequ
confirm
nativ
page
electrophoresi
transmiss
electron
microscopi
figur
complex
display
channelform
activ
defin
pore
size
activ
increas
acid
ph
sensit
adamantan
deriv
rimantadin
alkyl
iminosugar
nndnj
unpublish
data
demonstr
vitro
well
novel
small
molecul
inhibitor
gener
use
silico
model
channel
subsequ
dock
analysi
journal
volum
pagepag
fever
viru
csfv
respiratori
syncyti
viru
rsv
sh
provid
import
insight
activ
stoichiometri
predict
hexamer
use
silico
model
subsequ
confirm
nativ
page
electrophoresi
transmiss
electron
microscopi
figur
complex
display
channelform
activ
defin
pore
size
activ
increas
acid
ph
sensit
adamantan
deriv
rimantadin
alkyl
iminosugar
nndnj
unpublish
data
demonstr
vitro
well
novel
small
molecul
inhibitor
gener
use
silico
model
channel
subsequ
dock
analysi
predict
three
transmembran
domain
tmd
box
base
hydrophob
natur
amino
acid
membran
permeabil
assay
demonstr
carboxylterminu
extend
cytosol
aminoterminu
direct
toward
endoplasm
reticulum
er
lumen
first
tmd
give
rise
subcellular
local
mediat
bind
mhc
class
molecul
calnexin
second
tmd
facilit
recent
identifi
interact
transmembran
protein
well
subunit
h
atpas
function
increas
koilocytosi
activ
egfr
signal
induct
endosom
alkalin
exert
via
third
tmd
b
sequenc
obtain
uniprot
secondari
structur
predict
use
psipr
energi
minim
model
monom
contain
three
tmd
lowest
energi
use
build
hexamer
model
use
protocol
describ
previous
monom
model
minim
individu
restor
symmetri
refin
use
prime
schroding
inc
oligomer
state
confirm
nativ
page
transmiss
electron
microscopi
express
induc
anchorageindepend
growth
murin
cell
mitogen
effect
primari
human
foreskin
epitheli
cell
transform
recapitul
vivo
use
transgen
mous
model
express
epitheli
cell
control
promot
mice
express
associ
hyperplasia
tumor
format
number
studi
demonstr
import
epiderm
growth
figur
tmd
viroporin
predict
three
transmembran
domain
tmd
box
base
hydrophob
natur
amino
acid
membran
permeabil
assay
demonstr
carboxylterminu
extend
cytosol
aminoterminu
direct
toward
endoplasm
reticulum
er
lumen
first
tmd
give
rise
subcellular
local
mediat
bind
mhc
class
molecul
calnexin
second
tmd
facilit
recent
identifi
interact
transmembran
protein
well
subunit
h
atpas
function
increas
koilocytosi
activ
egfr
signal
induct
endosom
alkalin
exert
via
third
tmd
b
sequenc
obtain
uniprot
secondari
structur
predict
use
psipr
energi
minim
model
monom
contain
three
tmd
lowest
energi
use
build
hexamer
model
use
protocol
describ
previous
monom
model
minim
individu
restor
symmetri
refin
use
prime
schroding
inc
oligomer
state
confirm
nativ
page
transmiss
electron
microscopi
express
induc
anchorageindepend
growth
murin
cell
mitogen
effect
primari
human
foreskin
epitheli
cell
transform
recapitul
vivo
use
transgen
mous
model
express
epitheli
cell
control
promot
mice
express
associ
hyperplasia
tumor
format
number
studi
demonstr
import
epiderm
growth
factor
egf
receptor
egfr
transform
sinc
reinforc
genet
studi
show
transgen
mice
express
fail
produc
tumor
cross
mice
encod
inact
egfr
thu
contribut
host
cell
transform
appear
depend
manipul
egfr
studi
aim
understand
role
product
hpv
life
cycl
show
requir
maintain
prolif
statu
infect
cell
undergo
termin
differenti
order
allow
viru
genom
replic
moreov
caus
delay
earli
stage
keratinocyt
differenti
achiev
use
small
molecul
inhibitor
target
egfr
abl
show
process
also
depend
activ
egfr
signal
unpublish
data
precis
mechan
manipul
egfr
unclear
current
consensu
model
express
associ
deacidif
endosom
prevent
normal
degrad
traffick
pathway
would
culmin
deposit
activ
egfr
lysosom
termin
egfr
signal
express
cell
activ
egfr
appear
rerout
recycl
endosom
return
plasma
membran
maintain
mitogen
signal
deacidif
endosom
might
result
specif
interact
host
bind
partner
similar
iav
hepat
c
viru
might
indic
requir
direct
proton
channel
activ
support
idea
enhanc
egfr
signal
observ
express
cell
reduc
small
molecul
inhibitor
prevent
carboxyfluorescein
releas
vitro
dye
releas
assay
data
suggest
oncogen
activ
may
directli
link
viroporin
function
prove
case
would
repres
first
exampl
oncogen
viroporin
develop
specif
mutant
protein
lack
channel
activ
need
test
assay
order
valid
small
molecul
inhibitor
studi
fraught
offtarget
effect
moreov
great
interest
gener
virus
contain
mutant
order
studi
stage
hpv
life
cycl
put
viroporin
function
necessari
viroporin
function
describ
given
protein
highrisk
hpv
type
predict
adopt
similar
three
tmd
topolog
interest
determin
whether
viroporin
function
conserv
amongst
group
virus
whilst
presenc
defin
pore
size
nm
confirm
studi
futur
work
focu
determin
ion
select
channel
conclus
determin
whether
prefer
proton
whether
ion
select
fluctuat
depend
particular
membran
environ
shown
viroporin
final
although
thought
express
cervic
cancer
cell
due
integr
natur
genom
postul
play
role
earli
stage
cancer
develop
given
limit
treatment
option
alreadi
infect
hpv
ongo
research
develop
inhibitor
greater
potenc
suit
drug
develop
program
appear
feasibl
given
find
thu
potenti
drug
develop
target
yet
whether
ultim
prove
relev
postvaccin
era
remain
seen
viroporin
multifacet
viral
protein
shown
play
key
role
life
cycl
number
import
human
pathogen
rel
recent
identif
protein
encod
small
dna
tumor
virus
offer
opportun
understand
contribut
toward
product
life
cycl
virus
ultim
pathogenesi
analysi
viroporin
delet
mutant
virus
undoubtedli
help
delin
function
may
provid
import
insight
manipul
critic
host
function
larg
econom
health
burden
associ
viru
infect
alongsid
rapid
increas
resist
exist
therapeut
regim
avail
demonstr
need
new
antivir
drug
given
low
mutat
rate
dna
viru
genom
identifi
viru
encod
target
exemplifi
viroporin
present
attract
target
futur
therapeut
increas
understand
viroporin
structur
function
along
advent
high
throughput
technolog
hope
lead
develop
much
need
treatment
